Soluna Holdings, Inc (SLNH): Nasdaq/NYSE listing notice — Soluna Holdings receives Nasdaq minimum bid price deficiency notice; has until Oct 7, 2026 to regain compliance

Soluna Holdings, Inc

Closing bid price of common stock (SLNH) below $1.00 for 30 consecutive business days as of April 10, 2026.
180-day compliance period ends October 7, 2026; must trade at $1.00+ for 10 consecutive business days.
If not cured by Oct 7, the Company may qualify for a second 180-day period; otherwise delisting process begins.
Company states it will monitor the bid price and consider available strategies to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Soluna Holdings, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 10, 2026, Soluna Holdings, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the closing bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”), had been below $1.00 per share for the previous 30 consecutive business days, and that the Company is therefore not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing or trading of the Common Stock on the

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Soluna Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001493152-26-016620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.